PMA Supplement Guidelines At Last, But Industry Might Not Be Satisfied

FDA issued a long-awaited PMA supplement decision-making draft guidance March 9, sparking a round of applause from industry members attending AdvaMed's annual meeting in Chandler, Arizona

More from Archive

More from Medtech Insight